D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.47% |
| 2 | Consumer Discretionary | 13.31% |
| 3 | Healthcare | 13.17% |
| 4 | Financials | 7.14% |
| 5 | Industrials | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Outfront Media
OUT
$5.64B
| $9.93M | 0.01% |
431,316
-426,973
| -50% | -$8.95M |
|
1077
MDU Resources
MDU
$4.44B
| $9.92M | 0.01% |
1,009,823
-905,685
| -47% | -$8.79M |
|
1078
Spotify
SPOT
$99.2B
| $9.91M | 0.01% |
71,372
+3,522
| +5% | +$482K |
|
1079
Arrowhead Research
ARWR
$12.1B
| $9.89M | 0.01% |
539,158
+497,972
| +1,209% | +$8.21M |
|
1080
CALL
Equinix
EQIX
$107B
| $9.88M | 0.01% |
21,800
+16,400
| +304% | +$6.68M |
|
1081
CALL
Lockheed Martin
LMT
$134B
| $9.88M | 0.01% |
32,900
+17,900
| +119% | +$5.25M |
|
|
MCRN
1082
DELISTED
Milacron Holdings Corp.
MCRN
| $9.86M | 0.01% |
870,638
+285,384
| +49% | +$3.77M |
|
|
NUAN
1083
DELISTED
Nuance Communications, Inc.
NUAN
| $9.85M | 0.01% |
671,944
-177,803
| -21% | -$2.47M |
|
|
AVP
1084
DELISTED
Avon Products, Inc.
AVP
| $9.81M | 0.01% |
3,337,143
-233,464
| -7% | -$588K |
|
1085
National Vision
EYE
$1.6B
| $9.81M | 0.01% |
312,009
-664,680
| -68% | -$20.9M |
|
1086
PUT
Conagra Brands
CAG
$7.07B
| $9.77M | 0.01% |
+352,300
| New | +$8.08M |
|
1087
PACCAR
PCAR
$69.6B
| $9.76M | 0.01% |
214,952
+195,336
| +996% | +$8.5M |
|
|
GWPH
1088
PUT
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $9.76M | 0.01% |
57,900
-21,700
| -27% | -$3.23M |
|
|
GSKY
1089
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
| $9.75M | 0.01% |
753,725
+361,944
| +92% | +$4.13M |
|
|
HSII
1090
DELISTED
Heidrick & Struggles
HSII
| $9.75M | 0.01% |
254,286
+59,492
| +31% | +$2.15M |
|
1091
SLM Corp
SLM
$4.57B
| $9.73M | 0.01% |
982,078
+726,091
| +284% | +$7.51M |
|
1092
PUT
Diamondback Energy
FANG
$57.6B
| $9.73M | 0.01% |
95,800
-23,900
| -20% | -$2.45M |
|
1093
Cenovus Energy
CVE
$54.6B
| $9.68M | 0.01% |
1,114,248
+604,173
| +118% | +$5.02M |
|
1094
Belden
BDC
$4B
| $9.67M | 0.01% |
+180,148
| New | +$9.87M |
|
1095
CALL
Sarepta Therapeutics
SRPT
$1.66B
| $9.67M | 0.01% |
81,100
-65,000
| -44% | -$8.36M |
|
1096
Quanex
NX
$854M
| $9.66M | 0.01% |
607,757
+268,968
| +79% | +$4.27M |
|
1097
Rexford Industrial Realty
REXR
$8.7B
| $9.65M | 0.01% |
269,465
+112,302
| +71% | +$3.78M |
|
1098
PUT
Align Technology
ALGN
$12B
| $9.64M | 0.01% |
33,900
-9,500
| -22% | -$2.27M |
|
1099
CALL
iQIYI
IQ
$1.18B
| $9.63M | 0.01% |
+402,500
| New | +$8.89M |
|
|
HPP
1100
Hudson Pacific Properties
HPP
$834M
| $9.62M | 0.01% |
39,903
-71,319
| -64% | -$16.2M |
|
Similar funds
D.E. Shaw & Co's Q1 2019 Portfolio in Review
As of Q1 2019, D.E. Shaw & Co held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
D.E. Shaw & Co withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Lyft worth $159M.
- D.E. Shaw & Co's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- D.E. Shaw & Co added most to Pfizer in Q1 2019, an estimated $436M increase.
- D.E. Shaw & Co's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- D.E. Shaw & Co fully exited Shire pic in Q1 2019, selling an estimated $276M.
- D.E. Shaw & Co's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- D.E. Shaw & Co opened 447 new positions and closed 617 in Q1 2019.
- D.E. Shaw & Co's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.